HIVELOCITY, INC. – Trademark Portfolio
Entity Type: 03
HIVELOCITY, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include H, SPEEDYKVM, HIVELOCITY, and H HIVELOCITY. The owner is based in TAMPA, FL.
8010 WOODLANDS CENTER BLVD., SUITE 700
TAMPA, FL 33614
Showing of trademarks Trademarks
Trademark Classifications
HIVELOCITY, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does HIVELOCITY, INC. have?
HIVELOCITY, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 cancelled.
What trademark classes does HIVELOCITY, INC. file in?
HIVELOCITY, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are HIVELOCITY, INC.'s most well-known trademarks?
HIVELOCITY, INC.'s registered trademark portfolio includes well-known marks such as H, SPEEDYKVM, HIVELOCITY, and H HIVELOCITY. These are among 4 currently registered trademarks in the portfolio.
What is HIVELOCITY, INC.'s trademark registration success rate?
HIVELOCITY, INC. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.